Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05943964 · ClinicalTrials.gov registry record · NA

Virtual Rehabilitation in HCT

A NA study of Hematopoietic Cell Transplant, sponsored by Emory University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05943964 is a NA study of Hematopoietic Cell Transplant that is actively recruiting participants, run by Emory University. The registered enrollment target is 40 participants, below the 383-participant average among 6 other Hematopoietic Cell Transplant trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05943964, a NA study of Hematopoietic Cell Transplant, is actively recruiting participants, sponsored by Emory University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and improve QoL in chronic illnesses including GVHD, however, patients often have barriers to attending sessions including distance, risk of infection, and physical therapists' lack of experience with pediatric patients. The team's goal is to assess whether a virtual rehabilitation program in children post-HCT (including children with chronic GVHD) is feasible and whether its implementation will improve physical functioning and QoL. Patients between the ages of 8 and 23 years who are at least one hundred days post-HCT will be eligible for participation. Patients will have an assessment by a pediatric physical therapist at the time of study entry, at the end of the rehabilitation program, and approximately 3 months later. They will be supplied with some exercise equipment (such as dumbbells and resistance bands). Patients will have twice weekly half-hour one-on-one online sessions with the physical therapist for 12 weeks. Patients will be recruited through the bone marrow transplant clinic.

Conditions Studied

Hematopoietic Cell Transplant

Interventions

  • BEHAVIORAL Virtual exercise and rehabilitation program

Study Locations (1)

Georgia

  • Children's Healthcare of Atlanta - Atlanta

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2023-07-31
Est. Completion 2027-08
Phase NA

Sponsor

Emory University

1,208 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05943964

The ClinicalTrials.gov registry entry for NCT05943964 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 383-participant average among 6 other Hematopoietic Cell Transplant trials with a reported enrollment target (90% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hematopoietic Cell Transplant appearing as the primary indexed condition, and to 1 intervention - of which Virtual exercise and rehabilitation program is the first listed.

NCT05943964 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT05943964 about?

NCT05943964 is a clinical study titled "Virtual Rehabilitation in HCT". Chronic GVHD (cGVHD) is a major cause of illness in patients who undergo hematopoietic transplantation (HCT). GVHD can affect any organ in the body, can require several years of treatment, and can impact the quality of life (QoL). Physical activity and exercise have been shown to enhance fitness and...

What is the current status of trial NCT05943964?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-07-31. Estimated completion is 2027-08.

What conditions does trial NCT05943964 study?

This clinical trial studies the following conditions: Hematopoietic Cell Transplant.

What interventions are being tested in trial NCT05943964?

The interventions under investigation include: Virtual exercise and rehabilitation program (BEHAVIORAL).

Who is sponsoring clinical trial NCT05943964?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05943964 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Hematopoietic Cell Transplant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Hematopoietic Cell Transplant

All registered trials for this condition

Georgia

All trials with a study site in Georgia

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.